What is the main business of Apteki z Sercem?

The main business activity of Apteki z Sercem focuses on manufacture of basic pharmaceutical products.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 9, 2013.

Where is the headquarters located?

The headquarters is located at: Narutowicza 13 E, 70-240 Szczecin.

Who is on the management board?

The management board consists of: Iwona Izabella Gołębiowska (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

The company reported a revenue of USD 7,572 in 2025, which is a decrease of 7.4% compared to 2024.

Is the company profitable?

Yes, in 2025 the company was profitable, achieving a net profit of USD 4,317, meaning the company decreased its profit by 21.3%.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to USD 2,698 in 2025, representing 97% of all operating expenses.

Apteki z Sercemsp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2013-12-09

Share capital

5,000.00 PLN

Registered address

Narutowicza 13 E/Xiiie/14, 70-240 Szczecin, Poland

Financials

Revenue history

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 259 days for 2024). 1 of 6 audited by a statutory auditor.

202529/09/2026
202431/03/2026
202311/08/2024
202213/07/2023
202114/10/2022
202008/07/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Manufacture of basic pharmaceutical products39 / 46

Top 85%

Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations204 / 232

Top 88%

Sector · Manufacturing22,786 / 24,529

Top 93%

City · Szczecin3,963 / 4,620

Top 86%

Voivodeship · Zachodniopomorskie9,215 / 10,447

Top 88%

Country · Poland263,733 / 298,580

Top 88%

Results vs industry

Revenue

This companyUSD 7.57kMedianUSD 165.97kAverageUSD 2.30m

Net profit

This companyUSD 4.32kMedianUSD 1.32kAverageUSD 109.80k

Operating costs

This companyUSD 2.79kMedianUSD 201.81kAverageUSD 2.10m

Assets

This companyUSD 55.19kMedianUSD 118.27kAverageUSD 1.54m

Industry

Authorized Representatives

Iwona Izabella Gołębiowskaage 55 – President of the Management Board

Manner of representation

One member of the management board is authorised to make declarations of will and sign on behalf of the company up to the amount of PLN 200,000.00 (independent representation), and for an act exceeding the amount of PLN 200,000.00, joint action by two members of the management board together, or by one member of the management board jointly with a commercial proxy (joint representation), is required. Each member of the management board is authorised to make declarations of a non-property nature independently.

Ownership

Owner	Shares	Share value	Stake
Iwona Izabella Gołębiowskaage 55	91	$1,229.07	91%
Others	9	$121.56	9%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

	Name	Revenue	Website
	Bioresearch PharmaS.A.	$21,432.15	bioresearchpharma.com

Change history

Date	Event
2020-10-29	PKD change (Removed: 47.21.Z, 47.29.Z, 68.10.Z, 68.31.Z, 68.32.Z, 77.39.Z)
2013-12-09	Entered in the register

FAQ

Last updated: 2026-09-29